An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence

References 

1. Parkin DM, Moss SM. Lung cancer screening: improved survival but no reduction in deaths – the role of “overdiagnosis”. Cancer. 2000;89:2369–2376
   • MEDLINE
   • CrossRef
2. Morrison AS. Screening in chronic disease. Monographs in epidemiology and biostatistics. vol. 7. New York (NY): Oxford University Press; 1985;
3. Zappa M, Ciatto S, Bonardi R, Mazzotta A. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study. Ann Oncol. 1998;9:1297–1300
   • MEDLINE
   • CrossRef
4. von Karsa L, Anttila A, Ronco G, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening – First Report; 2008. <http://ec.europa.eu/health/ph_determinants/genetics/documents/cancer_screening.pdf>.
5. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol. 2007;8:1129–1138
   • Abstract
   • Full Text
   • Full-Text PDF (206 KB)
   • CrossRef
6. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?. J Med Screen. 2004;11:23–27
   • MEDLINE
   • CrossRef
7. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer. 2005;117:842–847
   • MEDLINE
   • CrossRef
8. Giorgi D, Ambrogetti D, Bianchi S, et al. Design and preliminary results of the Florence Breast Cancer Screening Programme (Progetto Firenze Donna). Eur J Cancer Prev. 1994;3(Suppl 1):29–34
   • CrossRef
9. Falini P, Giorgi D, Ventura L, Piccini P, Zappa M. I programmi di screening mammografico in Toscana. In: “I programmi di screening della regione toscana (Ottavo rapporto)”. A cura di Paola Mantellini. CSPO; 2007.
10. Ministero della Salute. Osservatorio Nazionale screening. <http://www.osservatorionazionalescreening.it/>.
11. Paci E, Miccinesi G, Puliti D, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res. 2006;8:R68
    • CrossRef
12. Paci E, Duffy S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res. 2005;7:266–270
    • CrossRef
13. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of overdiagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ. 2006;332:689–692
    • CrossRef
14. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res. 2005;7:230–234
    • CrossRef
15. Duffy SW, Agbaje O, Tabar L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Brit Cancer Res. 2005;7:258–265
16. Waller M, Moss S, Watson J, Møller H. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomark Prev. 2007;16:2257–2261
17. International Agency for Research on Cancer Expert Group. Breast Cancer Screening. In: IARC handbooks of cancer prevention, vol. 7. Lyon, France: IARC; 2002. p. 248.
18. Puliti D, Miccinesi G, Collina N, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Brit J Cancer. 2008;99:423–427
19. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. New Engl J Med. 2009;360:1320–1328